Triple negative breast cancers (TNBCs) are a relatively heterogeneous breast cancer subtype, broadly characterised by the absence of the oestrogen receptor (ER), progesterone receptor (PR) and HER2 (ERBB2), found in other subtypes of the disease [1]. Here, PGR is linked to triple-negative breast carcinoma.